Radiomics in prostate cancer: an up-to-date review
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Urology"
DOI: 10.1177/17562872221109020
Abstract: Prostate cancer (PCa) is the most common worldwide diagnosed malignancy in male population. The diagnosis, the identification of aggressive disease, and the post-treatment follow-up needs a more comprehensive and holistic approach. Radiomics is the extraction… read more here.
Keywords: date review; cancer date; prostate cancer; methodology ... See more keywords